Sanofi acquires Tidal Therapeutics, adding innovative mRNA-based research platform with applications in oncology, immunology, and other disease areas
10/04/2021
Sanofi announced on April 09th that it has acquired Tidal Therapeutics, a privately owned, pre-clinical [...]